First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects

Abstract

9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKEYWOS: 000447176600038

    Similar works